Researchers analyzed data from 28,299 COVID-19 patients hospitalized at 52 U.S. hospitals up to July 1.
Most hospitalized patients had at least one preexisting cardiovascular disease. About 50.4 percent of patients had hypertension. Of COVID-19 patients, 20.7 percent died in the hospital, but having heart failure increased mortality to 34.2 percent. Patients who had a cardiovascular event in a hospital also experienced high mortality rates.
Pharmaceutical Technology reported on the study Nov. 20, available here.
More articles on surgery center:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
